We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis.
- Authors
Mangel, J; Leitch, H A; Connors, J M; Buckstein, R; Imrie, K; Spaner, D; Crump, M; Pennell, N; Boudreau, A; Berinstein, N L
- Abstract
The outcome of 20 patients with newly diagnosed mantle-cell lymphoma (MCL) treated on a prospective trial of autologous stem-cell transplantation (ASCT) and rituximab immunotherapy was compared with the outcome of 40 matched historical control patients treated with standard combination chemotherapy.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Vol 15, Issue 2, p283
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1093/annonc/mdh069